Episurf Medical AB (publ) (STO:EPIS.B)

Episurf Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-86.6	-58.2	-76	-94.8	-77.3	-69.3
Depreciation & Amortization	6.2	5.6	6	6	5.1	5.3
Other Amortization	3.1	2.5	3	2.7	2.3	2.1
Stock-Based Compensation	0.3	0.3	1	0.7	-0.2	3.3
Other Operating Activities	0.7	0.6	-	-0.2	-0.3	-0.3
Change in Accounts Receivable	-1.4	-2.8	-0.8	0.4	-0.3	-1
Change in Inventory	0.8	0.2	0.5	-1.8	0.1	-
Change in Other Net Operating Assets	-17.8	-3.5	-5.1	2.2	1.1	0.2
Operating Cash Flow	-45.4	-55.3	-71.4	-84.8	-69.5	-59.7
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-0.2	-	-	-	-	-0.1
Sale (Purchase) of Intangibles	-7.8	-6.7	-7.6	-9.5	-11.3	-6.9
Investment in Securities	-	-	-	-	-	0.5
Other Investing Activities	-	-	-	-	0.1	-
Investing Cash Flow	-11.2	-6.7	-7.6	-9.5	-11.2	-6.5

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt Issued	44.1	-	-	-	-	-
Long-Term Debt Repaid	-	-3.6	-2.4	-3.2	-2.4	-2.4
Net Debt Issued (Repaid)	-4	-3.6	-2.4	-3.2	-2.4	-2.4
Issuance of Common Stock	43.2	29.7	90.2	0.2	0.5	159.6
Other Financing Activities	-17.2	-7.5	-16.2	-	-	-8
Financing Cash Flow	22	18.6	71.6	-3	-1.9	149.2

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Miscellaneous Cash Flow Adjustments	0.1	-	-	-0.1	-	-
Net Cash Flow	-34.5	-43.4	-7.4	-97.4	-82.6	83

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	-45.6	-55.3	-71.4	-84.8	-69.5	-59.8
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-174.71%	-273.76%	-346.60%	-428.28%	-1053.03%	-920.00%
Free Cash Flow Per Share	-0.04	-0.06	-0.15	-0.27	-0.26	-0.26
Levered Free Cash Flow	33.28	-40.4	-51.48	-60.26	-51.76	-40.46
Unlevered Free Cash Flow	36.71	-40.03	-50.85	-59.7	-51.33	-40.34

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	5.2	0.3	1	0.6	0.6	0.2
Change in Working Capital	30.9	-6.1	-5.4	0.8	0.9	-0.8

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error